ormulation technology for stabilized lipid-based nanoparticles (LNPs)

This was largely made possible by major advances in the formulation technology for stabilized lipid-based nanoparticles (LNPs). Design of the cationic ionizable lipids, which are a key component of the LNP formulations, with an acid dissociation constant (pKa) close to the early endosomal pH, would not only ensure effective encapsulation of mRNA into the stabilized lipoplexes within the LNPs, but also its subsequent endosomal release into the cytoplasm after endocytosis.
Unlike other gene therapy modalities, which require nuclear delivery, the site of action for exogenous mRNA vaccines is the cytosol where they get translated into antigenic proteins and thereby elicit an immune response. LNPs also protect the mRNA against enzymatic degradation by the omnipresent ribonucleases (RNases). Cationic nano emulsion (CNE) is also explored as an alternative and relatively thermostable mRNA vaccine delivery vehicle.
In this review, we have summarized the various delivery strategies explored for more details joplink Recombinant Human Serine  mRNA vaccines, including naked mRNA injection; ex vivo loading of dendritic cells; CNE; cationic peptides; cationic polymers, and finally the clinically successful COVID-19 LNP vaccines  (Pfizer/BioNTech and Moderna vaccines)-their components, design principles, formulation parameter optimization, and stabilization challenges. Despite the clinical success of LNP-mRNA vaccine formulations, there is a specific need to enhance their storage stability above 0 °C for these lifesaving vaccines to reach the developing.

Understanding the role of microperimetry in glaucoma

The present narrative review attempts to provide an overview on the use of microperimetry or fundus-driven perimetry in glaucoma, considering the clinical use, the different strategies and limits compared to standard automated perimetry.
 An electronic database (PubMed and Medline) search was performed of articles of any type published in the English language between 1998 and 2020 with a combination of the following terms: microperimetry, glaucoma, primary open-angle chronic glaucoma, visual field, Humphrey visual field, fundus automated perimetry.
All the original articles, case reports, and short series analyzed were included in the present review, offering an excursus on the strengths and limitations characterizing the use of microperimetry in glaucomatous patients. The characteristics of a recently introduced fundus-driven perimetry Compass (CMP; Centervue, Padua, Italy) were also included.
Although there remain several contradictions regarding routine use of microperimetry and the restricted research on this topic limits our ability to draw firm conclusions, microperimetry may be preferable in cases of localized retinal nerve fiber layer defects in patients with primary open-angle glaucoma and normal visual field. However, standard automated perimetry remains the gold standard for monitoring glaucoma, especially in patients with diffuse retinal nerve fiber layer impairment and visual field defects. The newly introduced Compass device can potentially provide a more accurate structural-functional evaluation than standard automated perimetry and can therefore produce superior testing reliability.

Ligand-Directed GPCR Antibody Discovery

Developing affinity reagents recognizing and modulating G-protein coupled receptors (GPCR) function by traditional animal immunization or in vitro screening methods is challenging. Some anti-GPCR antibodies exist on the market, but the success rate of development is still poor compared with antibodies targeting soluble or peripherally anchored proteins.

  • More importantly, most of these antibodies do not modulate GPCR function. The current pipeline for antibody development primarily screens for overall affinity rather than functional epitope recognition. We developed a new strategy utilizing natural ligand affinity to generate a library of antibody variants with an inherent bias toward the active site of the GPCR.
  • Instead of using phage libraries displaying antibodies with random CDR sequences at polymorphism sites observed in natural immune repertoire sequences, we generated focused antibody libraries with a natural ligand encoded within or conjugated to one of the CDRs or the N-terminus.
  • To tailor antibody binding to the active site, we limited the sequence randomization of the antibody in regions holstering the ligand while leaving the ligand-carrying part unaltered in the first round of randomization. With hits from the successful first round, the second round of randomization of the ligand-carrying part was then performed to eliminate the bias of the ligand.
  • Based on our results on three different GPCR targets, the proposed pipeline will enable the rapid generation of functional antibodies (both agonists and antagonists) against high-value targets with poor function epitope exposures including GPCR, channels, transporters as well as cell surface targets whose binding site is heavily masked by glycosylation.

endohedral trihedral metallo-borospherenes with spherical aromaticity

It is well-known that transition-metal-doping induces dramatic changes in the structures and bonding of small boron clusters, as demonstrated by the newly observed perfect inverse sandwich D8h [La(η8-B8)La] and D9h [La(η9-B9)La]. Based on extensive global minimum searches and first-principles theory calculations, we predict herein the possibility of perfect endohedral trihedral metallo-borospherene D3h La@[La5&B30] (1, 3A’1) and its monoanion Cs La@[La5&B30] (2, 2A’) and dianion D3h La@[La5&B30]2- (3, 1A’1).

These La-doped boron clusters are composed of three inverse sandwich La(η8-B8)La on the waist and two inverse sandwich La(η9-B9)La on the top and bottom which share one apex La atom at the center and six periphery B2 units between neighboring η8-B8 and η9-B9 rings, with three octo-coordinate La atoms and two nona-coordinate La atoms as integrated parts of the cage surface.

Detailed adaptive natural density partitioning (AdNDP) and iso-chemical shielding surface (ICSS) analyses indicate that La@[La5&B30]0/-/2- (1/2/3) are spherically aromatic in nature. The one-dimensional nanowire La4B21 (4, Pm) constructed from D3h La@[La5&B30] (1) along the C3 axis of the system appears to be metallic. The IR and Raman spectra of La@[La5&B30] (1) and photoelectron spectroscopy of the slightly distorted Cs La@[La5&B30] (2) are theoretically simulated to facilitate their spectroscopic characterizations.

Towards the saving of global rainforests

Rainforests are the Earth’s largest terrestrial carbon sinks and are rapidly shrinking due to unprecedented human impact, especially tropical rainforests, which host ~50% of global biodiversity. Understanding what makes rainforests resilient on a long-term basis is key to preserving global rainforests and their ecological services.
Here, using estimates of rates-of-change (RoC) in fossil pollen records, an indicator for temporal compositional change (turnover) in vegetation, we show that accelerating trends in global rainforest changes (increasing RoC/turnover) during the last 12,000 years were mainly driven by intensive agricultural practices, and the highly diverse and productive tropical rainforests were the most impacted.
Management/conservation strategies aimed at the effective management of human impact will help promote rainforest health and diversity and increase resilience under projected climate change.

Serine Racemase (Recombinant)

  • 230.00 EUR
  • 1483.00 EUR
  • 328.00 EUR
  • 1 µg
  • 50 ug
  • 5 ug

SRR Serine Racemase Human Recombinant Protein

Regular: 5ug 317 EUR

Recombinant human Thymus-specific serine protease

100ug Ask for price

Serine Hydroxymethyltransferase 1 (Recombinant)

  • 3418.00 EUR
  • 328.00 EUR
  • 230.00 EUR
  • 1 mg
  • 20 ug
  • 5 ug

Protease Serine 3 (Recombinant)

  • 3418.00 EUR
  • 328.00 EUR
  • 230.00 EUR
  • 1 mg
  • 20 ug
  • 5 ug

Serine Dehydratase-Like (Recombinant)

  • 328.00 EUR
  • 6397.00 EUR
  • 230.00 EUR
  • 10 ug
  • 1 mg
  • 2 µg

SHMT1 Serine Hydroxymethyltransferase 1 Human Recombinant Protein

Regular: 20ug 317 EUR

PRSS3 Protease Serine 3 Human Recombinant Protein

Regular: 20ug 317 EUR

PRSS7 Protease Serine 7 Human Recombinant Protein

Regular: 20ug 317 EUR

SDSL Serine Dehydratase-Like Human Recombinant Protein

Regular: 10ug 317 EUR

Fusogenic Viral Protein-Based Near-Infrared Active Nanocarriers for Biomedical

As a proof of concept, we bioengineered the vesicular stomatitis virus glycoprotein (VSV-G)-based near-infrared (NIR) active viral nanoconstructs (NAVNs) encapsulating indocyanine green dye (ICG) for NIR bioimaging.

NAVNs are spherical in size and have the intrinsic cellular-fusogenic properties of VSV-G. Further, the NIR imaging displaying higher fluorescence intensity in NAVNs treated cells suggests enhanced cellular uptake and delivery of ICG by NAVNs compared to the free form of ICG and for more information than visit joplink recombinant human to highlights. The overall study highlights the effectiveness of VSV-G-based VNPs as an efficient delivery system for NIR fluorescence imaging.

Phosphorylation of Trans-active response DNA binding protein-of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing

Trans-active response DNA-binding protein of 43 kDa (TDP-43) promotes tau mRNA instability and tau exon 10 inclusion. Aggregation of phosphorylated TDP-43 is associated with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). CK1ε phosphorylates TDP-43 at multiple sites, enhances its cytoplasmic aggregation and modu-lates its function in tau mRNA processing.

To determine roles of TDP-43 site-specific phos-phorylation in its localization, aggregation, and function in tau mRNA processing, TDP-43 was mutated to alanine or aspartic acid at Ser379, Ser403/404, or Ser409/410 to block or mimic phosphorylation. Site-specific phosphorylation of TDP-43 and its mutants by CK1ε was studied in vitro and in cultured cells. Cytoplasmic and nuclear TDP-43 and phospho-TDP-43 were analyzed by Western blots.

Aggregation of TDP-43 was assessed by immunostaining and level of RIPA-insoluble TDP-43. GFP tailed with tau 3′-UTR and mini-tau gene pCI/SI9-LI10 were used to study tau mRNA stability and alternative splicing of tau exon 10. We found that phospho-blocking mutations of TDP-43 at Ser379, Ser403/404, or Ser409/410 were not effectively phosphorylated by CK1ε.

Compared with TDP-43, higher level of phosphorylated TDP-43 in the cytoplasm was observed. Phospho-mimicking mutations at these sites enhanced cytoplasmic aggregation of TDP-43. GFP expression was not inhibited by phospho-blocking mutants of TDP-43, but tau exon 10 inclusion was further enhanced by phospho-blocking mutations at Ser379 and Ser403/404. Phosphorylation of TDP-43 at Ser379, Ser 403/404 or Ser409/410 primes its phosphorylation by CK1ε, promotes TDP-43 cytoplasmic aggregation and modulates its function in tau mRNA processing in site-specific manner.

Oncogenic mutations Q61L and Q61H confer active form-like structural features to the inactive state (state 1) conformation of H-Ras protein

GTP-bound forms of Ras proteins (Ras•GTP) assume two interconverting conformations, “inactive” state 1 and “active” state 2. Our previous study on the crystal structure of the state 1 conformation of H-Ras in complex with guanosine 5′-(β, γ-imido)triphosphate (GppNHp) indicated that state 1 is stabilized by intramolecular hydrogen-bonding interactions formed by Gln61. Since Ras are constitutively activated by substitution mutations of Gln61, here we determine crystal structures of the state 1 conformation of H-Ras•GppNHp carrying representative mutations Q61L and Q61H to observe the effect of the mutations.

The results show that these mutations alter the mode of hydrogen-bonding interactions of the residue 61 with Switch II residues and induce conformational destabilization of the neighboring regions. In particular, Q61L mutation results in acquirement of state 2-like structural features. Moreover, the mutations are likely to impair an intramolecular structural communication between Switch I and Switch II. Molecular dynamics simulations starting from these structures support the above observations. These findings may give a new insight into the molecular mechanism underlying the aberrant activation of the Gln61 mutants.

Effect of Active Coatings Containing Lippa citriodora Kunth. Essential Oil on Bacterial Diversity and Myofibrillar Proteins Degradation in Refrigerated Large Yellow Croaker

The research evaluated the effects of locust bean gum (LBG) and sodium alginate (SA) active coatings containing 0.15, 0.30 or 0.60% lemon verbena (Lippa citriodora Kunth.) essential oil (LVEO) on the bacterial diversity and myofibrillar proteins (MPs) of large yellow croaker during refrigerated storage at 4 °C for 18 days. Variability in the dominant bacterial community in different samples on the 0, 9th and 18th day was observed.

. Pseudomonas and Shewanella were the two major genera identified during refrigerated storage. At the beginning, the richness of Pseudomonas was about 37.31% and increased for control (CK) samples during refrigerated storage, however, the LVEO-treated samples increased sharply from day 0 to the 9th day and then decreased.

LBG-SA coatings containing LVEO treatments significantly delayed MPs oxidation by retarding the formation of free carbonyl compounds and maintaining higher sulfhydryl content, higher Ca2+-ATPase activity, better organized secondary (higher contents of α-helix and β-sheet) and tertiary structures during refrigerated storage.

The transmission electron microscope (TEM) images showed that the integrity of the sarcomere was damaged; the boundaries of the H-, A-, and I-bands, Z-disk, and M-line were fuzzy in the CK samples at the end of storage. However, the LVEO-treated samples were still regular in appearance with distinct dark A-bands, light I-bands, and Z-disk. In brief, LBG-SA active coatings containing LVEO treatments suggested a feasible method for protecting the MPs of large yellow croaker during refrigerated storage.

Ribosome-Inactivating Proteins of Bougainvillea glabra Uncovered Polymorphism and Active Site Divergence

Ribosome-inactivating proteins (RIPs) are toxic proteins that can inhibit protein synthesis. RIPs purified from Bougainvillea have low nonspecific toxicity, showing promise for processing applications in the agricultural and medical fields. However, systematic research on the polymorphism of Bougainvillea RIPs is lacking, and it is worth exploring whether different isoforms differ in their active characteristics. The transcriptional and translational expression of type I RIPs in Bougainvillea glabra leaves was investigated in this study. Seven RIPs exhibited seasonal variation at both the mRNA and protein levels.

The isoforms BI4 and BI6 showed the highest transcriptional expression in both the summer and autumn samples. Interestingly, BI6 was not detected in the protein level in any of the samples. However, the bioinformatics analysis showed that RIPs derived from the same species were gathered in a different cluster, and that the active sites changed among the isoforms during evolution.

The significant discrepancy in Bougainvillea RIPs mainly locates at both termini of the amino acid sequence, particularly at the C terminus. Post-translational modifications may also exist in Bougainvillea RIPs. It is concluded that the reason for the polymorphism of Bougainvillea RIPs may be that these proteins are encoded by multiple genes due to genetic processes such as gene duplication and mutation. According to the results of sequence analysis, the possible functional differences of B. glabra RIP isoforms are discussed with regard to the observed discrepancy in both active sites and structures.

 

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

48 Tests 511 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

96 Tests 709 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

48T 508 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

96T 661 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

48 Tests 534 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

96 Tests 742 EUR

C5AR1 Recombinant Protein (Human)

100 ug Ask for price

C5AR1 Recombinant Protein (Mouse)

100 ug Ask for price

C5AR1 Recombinant Protein (Mouse)

100 ug Ask for price

C5AR1 Recombinant Protein (Rat)

100 ug Ask for price

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).

The vital situation within the competitiveness between bioengineering and chemical engineering is the merchandise titer and the amount productiveness. Essentially the most direct and efficient method normally employs high-density biocatalyst, whereas the weakened mass switch and evoked foam downside accompany ultrahigh-density biocatalyst loading and substrate/product titer.

In high-density obligate cardio bioconversion, oxygen as electron acceptor is a speed-limiting step in bioprocesses, however ample oxygen provide will result in the foaming which ends up in a big discount in oxygen utilization and the usage of further defoamers. On this examine, we designed a novel sealed-oxygen provide (SOS) biotechnology to resolve the formidable barrier of oxygen transferring price (OTR), for bio-based fuels and chemical manufacturing course of.

Outcomes

Based mostly on systemic evaluation of whole-cell catalysis in Gluconobacter oxydans, a novel sealed-oxygen provide expertise was neatly designed and experimentally carried out for biocatalytic oxidation of alcohols, sugars and so forth. By a easy operation ability of computerized on-line provide of oxygen in a sealed stirring tank bioreactor of SOS, OTR barrier and foaming downside was resolved with nice ease.

We lastly obtained ultrahigh-titer merchandise of xylonic acid (XA), 3-hydroxypropionic acid (3-HPA), and erythrulose at 588.four g/L, 69.four g/L, and 364.7 g/L, respectively. Furthermore, the amount productiveness of three chemical merchandise was improved by 150-250% in contrast with regular biotechnology. This SOS expertise offers a promising method to advertise bioengineering competitiveness and benefits over chemical engineering.

SOS expertise was demonstrated as an financial and universally relevant method to bio-based fuels and chemical substances manufacturing by whole-cell catalysis. The novel expertise drastically promotes the competitiveness of bioengineering for chemical engineering, and offers a promising platform for the inexperienced and environmental use of biofuels.

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).
Resolving the formidable barrier of oxygen transferring price (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen provide biotechnology (SOS).

Panel 1: Biotechnology, biomedical engineering and new fashions of otitis media.

To summarize not too long ago revealed key articles on the matters of biomedical engineering, biotechnology and new fashions in relation to otitis media (OM).Digital databases: PubMed, Ovid Medline, Cochrane Library and Scientific Proof (BMJ Publishing).Articles on biomedical engineering, biotechnology, materials science, mechanical and animal fashions in OM revealed between Might 2015 and Might 2019 have been recognized and subjected to overview. A complete of 132 articles have been finally included.

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Mu-48Tests 48 Tests
EUR 429

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Mu-96Tests 96 Tests
EUR 591

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Ra-48Tests 48 Tests
EUR 450

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Ra-96Tests 96 Tests
EUR 622

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Hu-48T 48T
EUR 425
Description: A sandwich quantitative ELISA assay kit for detection of Human Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Hu-96T 96T
EUR 548
Description: A sandwich quantitative ELISA assay kit for detection of Human Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Mu-48T 48T
EUR 435
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Mu-96T 96T
EUR 561
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Ra-48T 48T
EUR 454
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Ra-96T 96T
EUR 587
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma or other biological fluids.

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Hu-48Tests 48 Tests
EUR 436

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Hu-96Tests 96 Tests
EUR 601

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Mu-48Tests 48 Tests
EUR 447

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Mu-96Tests 96 Tests
EUR 618

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Ra-48Tests 48 Tests
EUR 470

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Ra-96Tests 96 Tests
EUR 651

Human Epidermal Growth Factor Receptor (EGFR/Errb-1/HER1) ELISA Kit, 96 tests, quantitative

210-120-EGFR 1 kit
EUR 773

Mouse Epidermal Growth Factor Receptor (EGFR/Errb-1/HER1) ELISA Kit, 96 tests, quantitative

210-130-EGFR 1 Kit
EUR 773

EGFR Antibody

1-CSB-PA002264
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

EGFR Antibody

1-CSB-PA002267
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000

EGFR Antibody

1-CSB-PA002273
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/40000

EGFR Antibody

1-CSB-PA002275
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

EGFR Antibody

1-CSB-PA002281
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/5000

EGFR Antibody

1-CSB-PA005571LA01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200

EGFR Antibody

1-CSB-PA007479GA01HU
  • EUR 597.00
  • EUR 333.00
  • 150ul
  • 50ul
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

EGFR Antibody

1-CSB-PA007971
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

EGFR Antibody

1-CSB-PA007973
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000

EGFR Antibody

1-CSB-PA007976
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/5000

EGFR Antibody

1-CSB-PA007977
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

EGFR Antibody

1-CSB-PA007978
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

EGFR Antibody

1-CSB-PA10279A0Rb
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:500-1:1000

EGFR Antibody

1-CSB-PA162597
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:15-1:50

EGFR Antibody

23630-100ul 100ul
EUR 390

EGFR Antibody

36836-100ul 100ul
EUR 252

EGFR antibody

38493-100ul 100ul
EUR 252

EGFR Antibody

48691-100ul 100ul
EUR 333

EGFR Antibody

48691-50ul 50ul
EUR 239

EGFR Antibody

48714-100ul 100ul
EUR 333

EGFR Antibody

48714-50ul 50ul
EUR 239

EGFR Antibody

AF6041 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

AF6042 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

AF6043 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

AF6045 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

AF6046 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

AF6047 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

AF6049 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

AF6052 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of total EGFR.

EGFR Antibody

ABD7105 100 ug
EUR 438

EGFR Antibody

ABF0436 100 ug
EUR 438

EGFR Antibody

BF9105 200ul
EUR 376
Description: The EGFR antibody can recognize endogenous EGFR proteins.

EGFR Antibody

ABF6042 100 ug
EUR 438

EGFR Antibody

ABF6043 100 ug
EUR 438

EGFR Antibody

ABF6052 100 ug
EUR 438

EGFR Antibody

AF0436 200ul
EUR 304
Description: EGFR Antibody detects endogenous levels of EGFR.

EGFR Antibody

3782-100
EUR 338

EGFR antibody

20R-1723 100 ug
EUR 673
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-1940 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-1941 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2032 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2033 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2062 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2068 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2069 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2096 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2177 50 ug
EUR 281
Description: Goat polyclonal EGFR antibody

EGFR antibody

20R-2254 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2255 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2356 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2357 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2376 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2384 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2385 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2414 50 ug
EUR 281
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2688 50 ug
EUR 281
Description: Goat polyclonal EGFR antibody

EGFR antibody

20R-2968 100 ul
EUR 393
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER004 250 µL
EUR 670
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER022 50 ug
EUR 656
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER023 50 ug
EUR 656
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

10R-E101a 250 ug
EUR 965
Description: Mouse monoclonal EGFR antibody

EGFR antibody

20-ES04 250 ug
EUR 489
Description: Sheep polyclonal EGFR antibody

EGFR antibody

10R-1765 100 ul
EUR 316
Description: Mouse monoclonal EGFR antibody

EGFR antibody

10R-3131 100 ul
EUR 316
Description: Mouse monoclonal EGFR antibody

EGFR antibody

70R-17018 50 ul
EUR 435
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-30569 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-30571 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-31553 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-33569 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34091 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34093 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34095 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34097 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34099 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34101 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-35670 100 ug
EUR 327
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-11425 50 ug
EUR 197
Description: Rabbit polyclonal EGFR antibody for specific detection of the non-phosphorylated Ser1070 form of the EGFR peptide.

EGFR antibody

70R-12084 100 ul
EUR 436
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-49690 100 ul
EUR 287
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-49691 100 ul
EUR 244
Description: Purified Polyclonal EGFR antibody

New imaging applied sciences for the tympanic membrane (TM) and the center ear cavity are being developed to evaluate TM thickness, establish biofilms and differentiate kinds of center ear effusions. Synthetic intelligence (AI) has been utilized to coach software program applications to diagnose OM with a excessive diploma of certainty. Genetically modified mice fashions for OM have additional investigated what predisposes some people to OM and consequent listening to loss. New vaccine candidates defending in opposition to main otopathogens are being explored and developed, particularly mixed vaccines, concentrating on multiple pathogen.

Transcutaneous vaccination in opposition to non-typeable Haemophilus influenzae has been efficiently tried in a chinchilla mannequin. When it comes to remedy, novel applied sciences for trans-tympanic drug supply are getting into the scientific area. Varied development components and grafting supplies geared toward enhancing therapeutic of TM perforations present promising leads to animal fashions.

New applied sciences and AI purposes to enhance the analysis of OM have proven promise in pre-clinical fashions and are steadily getting into the scientific area. So are novel vaccines and drug supply approaches that will permit native remedy of OM.New diagnostic strategies, potential vaccine candidates and the novel trans-tympanic drug supply present promising outcomes, however are usually not but tailored to scientific use.

Growing a circular economy with fungal biotechnology: a white paper.

Growing a circular economy with fungal biotechnology: a white paper.

Fungi have the power to remodel natural supplies right into a wealthy and various set of helpful merchandise and supply distinct alternatives for tackling the pressing challenges earlier than all people. Fungal biotechnology can advance the transition from our petroleum-based financial system right into a bio-based round financial system and has the power to sustainably produce resilient sources of meals, feed, chemical compounds, fuels, textiles, and supplies for building, automotive and transportation industries, for furnishings and past.

Fungal biotechnology affords options for securing, stabilizing and enhancing the meals provide for a rising human inhabitants, whereas concurrently reducing greenhouse gasoline emissions.

Fungal biotechnology has, thus, the potential to make a big contribution to local weather change mitigation and assembly the United Nation’s sustainable growth objectives by means of the rational enchancment of latest and established fungal cell factories.

The White Paper offered right here is the results of the 2nd Assume Tank assembly held by the EUROFUNG consortium in Berlin in October 2019. This paper highlights discussions on present alternatives and analysis challenges in fungal biotechnology and goals to tell scientists, educators, most people, industrial stakeholders and policymakers in regards to the present fungal biotech revolution.

 Growing a circular economy with fungal biotechnology: a white paper.
Rising a round financial system with fungal biotechnology: a white paper.

The Integration and Harmonisation of Secular and Islamic Moral Ideas in Formulating Acceptable Moral Pointers for Trendy Biotechnology in Malaysia.

The Malaysian authorities recognises the potential contribution of biotechnology to the nationwide financial system. Nonetheless, ongoing controversy persists relating to its moral standing and no particular moral pointers have been printed referring to its use. In creating such pointers, you will need to establish the underlying rules which might be acceptable to Malaysian society. This paper discusses the method of figuring out related secular and Islamic moral rules and establishing their similarities earlier than harmonising them.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Mu-48T 48T
EUR 454
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Mu-96T 96T
EUR 587
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Ra-48T 48T
EUR 475
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Ra-96T 96T
EUR 616
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma or other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Hu-48Tests 48 Tests
EUR 439

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Hu-96Tests 96 Tests
EUR 606

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Mu-48Tests 48 Tests
EUR 450

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Mu-96Tests 96 Tests
EUR 622

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-48Tests 48 Tests
EUR 473

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-96Tests 96 Tests
EUR 655

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Hu-48Tests 48 Tests
EUR 458

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Hu-96Tests 96 Tests
EUR 633

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Mu-48Tests 48 Tests
EUR 470

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Mu-96Tests 96 Tests
EUR 651

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-48Tests 48 Tests
EUR 495

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-96Tests 96 Tests
EUR 685

EGFR2 ELISA KIT|Human

EF006774 96 Tests
EUR 689

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx128593
  • EUR 411.00
  • EUR 133.00
  • EUR 1149.00
  • EUR 565.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx130837
  • EUR 411.00
  • EUR 133.00
  • EUR 1149.00
  • EUR 565.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103702
  • EUR 425.00
  • EUR 133.00
  • EUR 1177.00
  • EUR 578.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103703
  • EUR 328.00
  • EUR 815.00
  • EUR 425.00
  • EUR 154.00
  • EUR 258.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103704
  • EUR 439.00
  • EUR 133.00
  • EUR 1247.00
  • EUR 592.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx172273
  • EUR 871.00
  • EUR 453.00
  • 1 mg
  • 200 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx176304
  • EUR 1177.00
  • EUR 578.00
  • 1 mg
  • 200 ug

Active Epidermal Growth Factor Receptor 2 (EGFR2)

4-APB867Hu01
  • EUR 745.12
  • EUR 302.00
  • EUR 2519.20
  • EUR 906.40
  • EUR 1712.80
  • EUR 562.00
  • EUR 6148.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Hu01
  • EUR 458.40
  • EUR 226.00
  • EUR 1444.00
  • EUR 548.00
  • EUR 996.00
  • EUR 370.00
  • EUR 3460.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Hu02
  • EUR 458.40
  • EUR 226.00
  • EUR 1444.00
  • EUR 548.00
  • EUR 996.00
  • EUR 370.00
  • EUR 3460.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Mu01
  • EUR 490.66
  • EUR 234.00
  • EUR 1564.96
  • EUR 588.32
  • EUR 1076.64
  • EUR 391.00
  • EUR 3762.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Ra01
  • EUR 494.24
  • EUR 235.00
  • EUR 1578.40
  • EUR 592.80
  • EUR 1085.60
  • EUR 394.00
  • EUR 3796.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Epidermal Growth Factor Receptor 2 expressed in: E.coli

Human Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066444
  • EUR 648.00
  • EUR 272.00
  • EUR 1943.00
  • EUR 759.00
  • EUR 467.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Rat Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066445
  • EUR 690.00
  • EUR 286.00
  • EUR 2124.00
  • EUR 815.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066447
  • EUR 690.00
  • EUR 286.00
  • EUR 2110.00
  • EUR 815.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx168780
  • EUR 648.00
  • EUR 272.00
  • EUR 1943.00
  • EUR 759.00
  • EUR 467.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (FITC)

20-abx271123
  • EUR 467.00
  • EUR 244.00
  • EUR 1358.00
  • EUR 648.00
  • EUR 356.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (FITC)

20-abx271195
  • EUR 495.00
  • EUR 258.00
  • EUR 1455.00
  • EUR 690.00
  • EUR 398.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (Biotin)

20-abx271389
  • EUR 439.00
  • EUR 244.00
  • EUR 1261.00
  • EUR 606.00
  • EUR 328.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (Biotin)

20-abx271461
  • EUR 467.00
  • EUR 244.00
  • EUR 1344.00
  • EUR 634.00
  • EUR 356.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

20-abx153942
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx573292-96tests 96 tests
EUR 786

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx573464-96tests 96 tests
EUR 707

Human Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

20-abx493188
  • EUR 7973.00
  • EUR 4246.00
  • EUR 981.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

20-abx493189
  • EUR 8569.00
  • EUR 4560.00
  • EUR 1052.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rat Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

20-abx493190
  • EUR 7973.00
  • EUR 4246.00
  • EUR 981.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Epidermal Growth Factor Receptor 2 (EGFR2)ELISA Kit

201-12-2674 96 tests
EUR 440
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Pig Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx361560-96tests 96 tests
EUR 754

Rabbit Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx363428-96tests 96 tests
EUR 754

Chicken Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx356052-96tests 96 tests
EUR 754

Monkey Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx359784-96tests 96 tests
EUR 754

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

20-abx155460
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

abx195583-96tests 96 tests
EUR 825

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

20-abx151385
  • EUR 7112.00
  • EUR 3792.00
  • EUR 879.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Epidermal Growth Factor Receptor 2 ELISA Kit (EGFR2)

RK01301 96 Tests
EUR 521

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human)

4-MAB867Hu21
  • EUR 251.00
  • EUR 2582.00
  • EUR 641.00
  • EUR 316.00
  • EUR 215.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2)

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human)

4-MAB867Hu22
  • EUR 247.00
  • EUR 2523.00
  • EUR 628.00
  • EUR 311.00
  • EUR 214.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2)

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-10x96wellstestplate 10x96-wells test plate
EUR 4502.43
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-1x48wellstestplate 1x48-wells test plate
EUR 458.44
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-1x96wellstestplate 1x96-wells test plate
EUR 612.05
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-5x96wellstestplate 5x96-wells test plate
EUR 2454.23
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

4-SEB867Hu
  • EUR 4553.00
  • EUR 2405.00
  • EUR 613.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-10x96wellstestplate 10x96-wells test plate
EUR 4626.78
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-1x48wellstestplate 1x48-wells test plate
EUR 468.68
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-1x96wellstestplate 1x96-wells test plate
EUR 626.68
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-5x96wellstestplate 5x96-wells test plate
EUR 2520.06
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

4-SEB867Mu
  • EUR 4677.00
  • EUR 2471.00
  • EUR 627.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-10x96wellstestplate 10x96-wells test plate
EUR 4875.49
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-1x48wellstestplate 1x48-wells test plate
EUR 489.16
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-1x96wellstestplate 1x96-wells test plate
EUR 655.94
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-5x96wellstestplate 5x96-wells test plate
EUR 2651.73
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

4-SEB867Ra
  • EUR 4926.00
  • EUR 2602.00
  • EUR 656.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from Serum, plasma and other biological fluids. with no significant corss-reactivity with analogues from other species.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human)

4-PAB867Hu01
  • EUR 239.00
  • EUR 2391.00
  • EUR 598.00
  • EUR 299.00
  • EUR 211.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2)

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse)

4-PAB867Mu01
  • EUR 243.00
  • EUR 2457.00
  • EUR 613.00
  • EUR 305.00
  • EUR 212.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2)

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat)

4-PAB867Ra01
  • EUR 251.00
  • EUR 2589.00
  • EUR 643.00
  • EUR 317.00
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2)

Human Epidermal Growth Factor Receptor 2(EGFR2)ELISA Kit

QY-E04124 96T
EUR 361

Human EGFR2(Epidermal Growth Factor Receptor 2) ELISA Kit

EH2981 96T
EUR 524.1
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 75pg/ml

ELISA kit for Mouse EGFR2 (Epidermal Growth Factor Receptor 2)

E-EL-M2666 1 plate of 96 wells
EUR 534
Description: A sandwich ELISA kit for quantitative measurement of Mouse EGFR2 (Epidermal Growth Factor Receptor 2) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Human EGFR2 (Epidermal Growth Factor Receptor 2)

ELK2233 1 plate of 96 wells
EUR 432
Description: A sandwich ELISA kit for detection of Epidermal Growth Factor Receptor 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Mouse EGFR2 (Epidermal Growth Factor Receptor 2)

ELK2659 1 plate of 96 wells
EUR 432
Description: A sandwich ELISA kit for detection of Epidermal Growth Factor Receptor 2 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Rat EGFR2 (Epidermal Growth Factor Receptor 2)

ELK5785 1 plate of 96 wells
EUR 432
Description: A sandwich ELISA kit for detection of Epidermal Growth Factor Receptor 2 from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Human EGFR2 (Epidermal Growth Factor Receptor 2)

E-EL-H1629 1 plate of 96 wells
EUR 534
Description: A sandwich ELISA kit for quantitative measurement of Human EGFR2 (Epidermal Growth Factor Receptor 2) in samples from Serum, Plasma, Cell supernatant

CLIA kit for Human EGFR2 (Epidermal Growth Factor Receptor 2)

E-CL-H1044 1 plate of 96 wells
EUR 584
Description: A sandwich CLIA kit for quantitative measurement of Human EGFR2 (Epidermal Growth Factor Receptor 2) in samples from Serum, Plasma, Cell supernatant

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), APC

4-MAB867Hu21-APC
  • EUR 352.00
  • EUR 3374.00
  • EUR 937.00
  • EUR 449.00
  • EUR 222.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Biotinylated

4-MAB867Hu21-Biotin
  • EUR 316.00
  • EUR 2532.00
  • EUR 745.00
  • EUR 388.00
  • EUR 221.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Cy3

4-MAB867Hu21-Cy3
  • EUR 428.00
  • EUR 4457.00
  • EUR 1208.00
  • EUR 558.00
  • EUR 254.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), FITC

4-MAB867Hu21-FITC
  • EUR 302.00
  • EUR 2719.00
  • EUR 769.00
  • EUR 379.00
  • EUR 197.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), HRP

4-MAB867Hu21-HRP
  • EUR 322.00
  • EUR 2940.00
  • EUR 828.00
  • EUR 406.00
  • EUR 209.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), PE

4-MAB867Hu21-PE
  • EUR 302.00
  • EUR 2719.00
  • EUR 769.00
  • EUR 379.00
  • EUR 197.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), APC

4-MAB867Hu22-APC
  • EUR 346.00
  • EUR 3293.00
  • EUR 917.00
  • EUR 441.00
  • EUR 220.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Biotinylated

4-MAB867Hu22-Biotin
  • EUR 312.00
  • EUR 2473.00
  • EUR 730.00
  • EUR 382.00
  • EUR 219.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Cy3

4-MAB867Hu22-Cy3
  • EUR 420.00
  • EUR 4349.00
  • EUR 1181.00
  • EUR 547.00
  • EUR 252.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), FITC

4-MAB867Hu22-FITC
  • EUR 297.00
  • EUR 2654.00
  • EUR 753.00
  • EUR 373.00
  • EUR 196.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), HRP

4-MAB867Hu22-HRP
  • EUR 316.00
  • EUR 2870.00
  • EUR 811.00
  • EUR 399.00
  • EUR 207.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), PE

4-MAB867Hu22-PE
  • EUR 297.00
  • EUR 2654.00
  • EUR 753.00
  • EUR 373.00
  • EUR 196.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), APC

4-PAB867Hu01-APC
  • EUR 333.00
  • EUR 3113.00
  • EUR 872.00
  • EUR 423.00
  • EUR 215.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), Biotinylated

4-PAB867Hu01-Biotin
  • EUR 303.00
  • EUR 2341.00
  • EUR 697.00
  • EUR 369.00
  • EUR 216.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), Cy3

4-PAB867Hu01-Cy3
  • EUR 403.00
  • EUR 4109.00
  • EUR 1121.00
  • EUR 523.00
  • EUR 245.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), FITC

4-PAB867Hu01-FITC
  • EUR 287.00
  • EUR 2510.00
  • EUR 717.00
  • EUR 359.00
  • EUR 192.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), HRP

4-PAB867Hu01-HRP
  • EUR 305.00
  • EUR 2714.00
  • EUR 772.00
  • EUR 383.00
  • EUR 203.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), PE

4-PAB867Hu01-PE
  • EUR 287.00
  • EUR 2510.00
  • EUR 717.00
  • EUR 359.00
  • EUR 192.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

To attain this, a sequence of focus group discussions had been performed with 23 information consultants representing varied stakeholders within the biotechnology neighborhood. Notably, a number of rules between the secular and Islamic views are not directly or straight related.

All of the consultants agreed with the predominant six moral rules of secular and Islamic philosophy and their significance and relevance in trendy biotechnology.

These are beneficence and non-maleficence as the primary or overarching rules, the preservation of spiritual and ethical values, the preservation of the mind and the thoughts, the safety of human security, the safety of future generations, and safety of the surroundings and organic range. A number of changes had been made to the terminologies and definitions of those six rules to formulate acceptable guiding rules for the ethics of contemporary biotechnology in Malaysia.

These can then be adopted as core values to underpin future nationwide pointers on trendy biotechnology ethics. These rules can be notably essential in guiding the coverage makers, enforcers, industries and researchers to streamline their actions. In so doing, trendy biotechnology and its merchandise might be correctly managed with out jeopardising the pursuits of the Muslim neighborhood in addition to most people.

Importantly, they’re expansive and inclusive sufficient to embrace the non secular sensitivity of various quarters of Malaysia.

Argentina’s Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?

Argentina's Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?

Plant biotechnology in Argentina started at the end of the 1980s, leading to the development of numerous research groups in public institutions and, a decade later, to some local private initiatives. The numerous scientific and technological capacities existing in the country allowed the early constitution in 1991 of a sound genetically modified organisms biosafety regulatory system.

The first commercial approvals began in 1996, and to date, 59 events have obtained permits to be placed on the market, however, only two have been developed locally by public-private partnerships. The transgenic events developed at public institutions pursue different objectives in diverse crops.

However, once these events have been developed in laboratories, it is difficult to move toward a possible commercial approval. In this work, we analyze several reasons that could explain why local developments have not reached approvals for commercialization, highlighting aspects related to the lack of strategic vision in the institutions to focus resources on projects to develop biotechnological products.

Although progress has been made in generating regulatory rules adapted to research institutes (such as the regulations for biosafety greenhouses and ways of presenting applications), researchers still do not conceive regulatory science as a discipline. They generally prefer not to be involved in the design of regulatory field trials or regulatory issues related to the evaluation of events. In that sense, some of the aspects considered a regulatory affairs platform for the public scientific system and the reinforcement of laboratories that perform tests required under the Argentine regulation.

Argentina's Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?
Argentina’s Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?

Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.

Forty-three years after it was founded, with billions of dollars invested, the global biotech industry is still not positioned as a mature low-risk sector for the international investor com-munity.

Despite the clear commercial success of a number of leading companies and overall growth of the industry’s rev-enues, most biotech companies are not profi table and many fail to overcome the formidable barrier constituted by the high cost of the sector’s research and development. However, over the last four years, visible signs of change have appeared, which could be harbingers of an approaching turning point in this trend.

This article analyzes the historic background of the biotech in-dustry’s business models and corporate structures, as well as their impact on the industry’s fi nancial framework. It examines recent changes implemented by the sector’s main actors-in-cluding young startups, venture capital funds and big pharma companies-to mitigate fi nancial risk associated with develop-ment of new biotechnology products.

EGTA

abx082565-5g 5 g
EUR 189

EGTA

GE7249-100G 100 g
EUR 150

EGTA

GE7249-10G 10 g
EUR 52

EGTA

GE7249-25G 25 g
EUR 70

EGTA

GE7249-50G 50 g
EUR 98

EGTA

B7195-1000 1 g
EUR 106

EGTA-AM

HY-D0973 5mg
EUR 587

EGTA, 99%

GE9981-100G 100 g
EUR 181

EGTA, 99%

GE9981-10G 10 g
EUR 61

EGTA, 99%

GE9981-250G 250 g
EUR 333

EGTA, 99%

GE9981-25G 25 g
EUR 84

EGTA, 99%

GE9981-50G 50 g
EUR 120

EGTA AM *CAS 99590-86-0*

21005 10 mg
EUR 176

EGTA AM *10 mM DMSO solution*

21006 1 mL
EUR 176

EGTA tetrasodium salt *CAS 13368-13-3*

21007 1 g
EUR 115

EGTA tetrasodium salt *10 mM aqueous solution*

21008 10 mL
EUR 115

2xRIPA Buffer IIII with EDTA and EGTA (pH 7.4) 2xconcentrate

RB4477 500ml
EUR 71.75

Finally, it discusses the challenges and opportunities that these tendencies entail for Cuban biotechnology development and proposes adoption of business policies more tolerant of the fi nancial risk inherent in this sector, as a condition for at-tracting venture capital. KEYWORDS Biotechnology, fund raising, risk management, entrepreneurship, Cuba.